Symbols / RLY
RLY Chart
About
Under normal circumstances, the Adviser invests at least 80% of the net assets of the fund among ETPs that provide exposure to the following primary asset classes: (i) inflation protected securities issued by the United States government; (ii) domestic and international real estate securities; (iii) commodities; (iv) publicly-traded domestic and international infrastructure companies; and (iv) publicly-traded companies in natural resources and/or commodities businesses.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | 282.00% |
| Payout | — | Employees | — | IPO | — |
| P/E | 20.53 | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 36.36 | 52W Low | 25.63 |
| Beta | — | Avg Volume | 173.26K | Volume | 187.41K |
| Target Price | — | Recom | — | Prev Close | $35.48 |
| Price | $35.67 | Change | 0.54% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
News
RSS: Latest RLY news- What was really behind Jack Dorsey laying off nearly half of Block’s staff? - The Guardian ue, 03 Mar 2026 16
- Liquidity Mapping Around (RLY) Price Events - Stock Traders Daily Fri, 27 Feb 2026 02
- Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance Sun, 21 Sep 2025 07
- Relay Therapeutics’ SWOT analysis: AI-driven biotech stock faces pivotal phase - Investing.com hu, 18 Sep 2025 07
- Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025 - Yahoo Finance Fri, 12 Dec 2025 08
- Rly stocks on a roll with gains up to 12% powered by fare hikes, mega budget expectations - Fortune India Fri, 26 Dec 2025 08
- Why Railway Stocks are Rising - Equitymaster Fri, 26 Dec 2025 08
- An alpha turnaround for Relay | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline Mon, 09 Sep 2024 07
- Real Asset ETFs: Really Underappreciated - ETF Trends hu, 21 Nov 2024 08
- Sr rly board official checks new metro stretches ahead of likely launch by PM, chairman may visit city to - The Times of India Mon, 11 Aug 2025 07
- RLY: More Of A Cyclical Play Than A Portfolio Diversifier (NYSEARCA:RLY) - Seeking Alpha hu, 14 Mar 2024 07
- Railway Revamp: Progress in electrification, expansion and rolling stock modernisation - Indian Infrastructure Magazine hu, 18 Sep 2025 07
- Relay cuts more staff in efforts to save $50M a year - Fierce Biotech hu, 03 Oct 2024 07
- Alstom Delivers 500th Electric Locomotive to Indian Railways - Railway-News Wed, 26 Mar 2025 07
- 4 Stocks That Are Too Cheap to Ignore - The Motley Fool Mon, 27 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for RLY
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|